Trial
NCT02591199
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Urigen
Collaborators
—
Condition
Interstitial Cystitis
Intervention
URG101
Why stopped
Prematurely terminated due to data inconsistent with the experimental plan and lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03